September 27, 2016 8:17 PM ET

Biotechnology

Company Overview of Genzyme Corporation

Company Overview

Genzyme Corporation, a biotechnology company, engages in the discovery and development of products and services primarily in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases, and endocrinology. It offers Cerezyme to treat gaucher disease type I; Fabrazyme to treat fabry disease; Aldurazyme for mucopolysaccharidosis I; Myozyme and Lumizyme for pompe disease; Renagel that reduces phosphorous levels in chronic kidney disease (CKD) patients who are on dialysis; Renvela for use in dialysis patients and patients with earlier stage CKD; Hectorol, a vitamin D2 treatment for secondary hyperparathyroidism in CKD patients; Thyrogen to use in thyroid cancer follow-up; Leuk...

500 Kendall Street

Cambridge, MA 02142

United States

Founded in 1981

10,100 Employees

Phone:

617-252-7500

Fax:

617-252-7600

Key Executives for Genzyme Corporation

Chief Executive Officer and President
Age: 61
Chief Financial Officer
Executive Vice President and President of Manufacturing & Corporate Operations
Age: 55
President of Surgical Products
Age: 67
Executive Vice President of Legal, Executive Vice President of Corporate Development and Secretary
Age: 66
Compensation as of Fiscal Year 2016.

Genzyme Corporation Key Developments

Genzyme Corporation Presents at Leerink Healthcare Summit, Sep-23-2016 11:15 AM

Genzyme Corporation Presents at Leerink Healthcare Summit, Sep-23-2016 11:15 AM. Venue: Napa Valley, California, United States. Speakers: Henri Termeer, Former CEO, Chairman & President.

Genzyme Corporation Presents at FT Global Pharmaceutical and Biotechnology Conference 2015, Nov-16-2015 02:35 PM

Genzyme Corporation Presents at FT Global Pharmaceutical and Biotechnology Conference 2015, Nov-16-2015 02:35 PM. Venue: Marriott Hotel, Grosvenor Square, London W1K 6JP, United Kingdom. Speakers: David P. Meeker, Chief Executive Officer and President.

Genzyme Corporation Presents at BioPharm America 2015, Sep-15-2015 01:30 PM

Genzyme Corporation Presents at BioPharm America 2015, Sep-15-2015 01:30 PM. Venue: Boston Marriott Copley Place, 110 Huntington Avenue, Boston, MA 02116, United States. Speakers: Henri A. Termeer, Executive Director, Member of Strategic Planning & Capital Allocation Committee and Member of Risk Oversight Committee.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Genzyme Corporation, please visit www.genzyme.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.